You can buy or sell Eli Lilly and other stocks, options, ETFs, and crypto commission-free!
Eli Lilly & Co. engages in the discovery, development, manufacture and sale of pharmaceutical products. It operates through the following segments: Human Pharmaceutical Products and Animal Health Products. Read More The Human Pharmaceutical products segment includes the discovery, development, manufacturing, marketing and sales of human pharmaceutical products worldwide in the following therapeutic areas: neuroscience, endocrinology, oncology, cardiovascular and other. The Animal health Products segment operating through the Elanco Animal Health division, develops, manufactures, and markets products for both food and companion animals. The Animal health products include Rumensin, Tylan, Posilac, Paylean and other products for livestock and poultry, as well as Trifexis, Comfortis, and other products for companion animals. The company was founded by Eli Lilly on May 1876 and is headquartered in Indianapolis, IN.
52 Week High
52 Week Low
Health And Wellness
Yahoo FinanceMay 22
Eli Lilly says lower-priced insulin is now available
Yahoo Finance's Alexis Christoforous and Brian Sozzi speak to Christi Shaw, President of Eli Lilly Bio-Medicines about the company's low cost insulin drug and new line of migraine drugs.
Washington PostMay 22
Lilly selling half-price version of popular Humalog insulin
FILE - This April 26, 2017, file photo shows the Eli Lilly and Co. corporate headquarters in Indianapolis. A half-price version of Eli Lilly’s popular Humalog insulin is now available, following the company’s promise in March to offer diabetics a more affordable option amid fierce criticism of soaring insulin prices. Lilly, one of the three top insulin makers, said Wednesday, May 22, 2019, that it’s begun selling its own generic version of Humalog U-100 under the chemical name, Insulin Lispro. (Darron Cummi...
Available Jul 30, Pre-Market